ArticleJournal of cellular and molecular medicine2022

Targeting VEGF with bevacizumab inhibits malignant effusion formation of primary human herpesvirus 8-unrelated effusion large B-cell lymphoma in vivo.

Fumiya Ogasawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.